RLMD

Relmada Therapeutics, Inc. is a clinical-stage biotechnology firm headquartered in New York, dedicated to pioneering novel therapies for central nervous system (CNS) disorders and related conditions. The company is advancing a promising pipeline targeting unmet medical needs in pain management and psychiatric disorders, leveraging innovative research and technology. With a strong emphasis on improving patient outcomes, Relmada is well-positioned to play a pivotal role in the dynamic CNS therapeutics landscape, potentially delivering transformative solutions for both patients and healthcare providers.